Urinary copper excretion in type 2 diabetic patients with nephropathy

Nephron

Volumn 88, Issue 4, 2001, Pages 307-312

  Ito, Seiki ^a   Fujita, Hiroki ^a   Narita, Takuma ^a   Yaginuma, Toshiko ^a   Kawarada, Yoshihiko ^a   Kawagoe, Masami ^a   Sugiyama, Toshihiro ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic nephropathy; Type 2 diabetes; Urinary copper excretion

Indexed keywords

ACETYLGLUCOSAMINIDASE; ALBUMIN; ALPHA 1 MICROGLOBULIN; CERULOPLASMIN; COPPER; CREATININE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DISSOCIATION; FEMALE; GLOMERULUS; HUMAN; KIDNEY TUBULE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PH; PRIORITY JOURNAL; PROTEINURIA; SERUM; URINARY EXCRETION;

AGED; ALBUMINURIA; CERULOPLASMIN; COPPER; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY TUBULES; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0034939396     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046013     Document Type: Article

References (38)

1. The clinical course of idiopathic membranous nephropathy
2. Prognostic indicators in idiopathic IgA mesangial nephropathy
3. The effect of dietary protein restriction and blood pressure control on the progression of chronic renal disease
4. The role of proteinuria in the progression of chronic renal failure
5. Enzymuria as a marker of renal injury and disease: Studies of N-acetyl-β-glucosaminidase in the general population and in patients with renal disease
6. Urinary albumin, transferrin and iron excretion in diabetic patients
7. Elevated urinary excretion of the C5b-9 complex membranous nephropathy
8. Serum and urinary lipoproteins in the human nephrotic syndrome: Evidence for renal catabolism of lipoproteins
9. Urinary excretion rate of ceruloplasmin in non-insulin dependent diabetic patients with different stages of nephropathy
10. Bioactivity of glomerular ultra-filtrate during heavy proteinuria may contribute to renal tubulo-intestinal lesions
11. Absorption, transport, and hepatic metabolism of copper and zinc: Special reference to metallothionein and ceruloplasmin
12. Complexes of salicyaldehyde acylhydrazones: Cytotoxicity, QSAR and crystal structure of the sterically hindered t-butyl dimer
13. The effect of silver administration on the biosynthesis and the molecular properties of rat ceruloplasmin
14. An immunoassay method for urinary albumin at low concentrations
15. 1-microglobulin: Its measurement and clinical significance
16. The excretion of N-acetyl-β-glucosaminidase and β-galactosidase by patients with renal disease
17. Copper levels in plasma and erythrocytes in healthy Japanese children and adults
18. Serum copper and ceruloplasmin levels and urinary copper excretion in thermal injury
19. Plasma levels of immunoreactive ceruloplasmin and acute phase proteins during lactation
20. Serum and plasma ceruloplasmin in humans
21. Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase)
22. Binding of transition metal ions by ceruloplasmin (ferroxidase)
23. Copper metabolism in normal subjects
24. The question of copper deficiency in man
25. Studies on copper metabolism. XVI. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration
26. Studies on copper metabolism. IX. The transportation of copper in blood
27. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies
28. Charge selectivity of proteinuria in diabetic glomerulopathy
29. Pathogenesis of incipient nephropathy; hypothesis
30. Mechanism of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier
31. Renal albumin reabsorption in normal and sodium maleate-treated rats
32. Proteinuria in diabetes mellitus: Role of spontaneous and experimental variation of glycemia
33. Relationship between the urinary excretion of albumin and retinol-binding protein in insulin-dependent diabetics
34. Wilson's disease with reversible renal tubular dysfunction
35. New occupational risk factors for chronic renal failure
36. Fragmentation of ceruloplasmin following non-enzymatic glycation reaction